Rani Therapeutics Holdings Inc (NASDAQ: RANI) started the day on Thursday, with a price increase of 1.15% at $2.63, before settling in for the price of $2.60 at the close. Taking a more long-term approach, RANI posted a 52-week range of $1.82-$8.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 83.82% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 0.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.44%. This publicly-traded company’s shares outstanding now amounts to $26.04 million, simultaneously with a float of $14.99 million. The organization now has a market capitalization sitting at $77.03 million. At the time of writing, stock’s 50-day Moving Average stood at $2.54, while the 200-day Moving Average is $3.74.
Rani Therapeutics Holdings Inc (RANI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Rani Therapeutics Holdings Inc’s current insider ownership accounts for 48.82%, in contrast to 6.68% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’24, this organization’s 10% Owner sold 3,829,360 shares at the rate of 2.65, making the entire transaction reach 10,141,674 in total value, affecting insider ownership by 8,302,194. Preceding that transaction, on Nov 24 ’23, Company’s 10% Owner sold 5,265,165 for 2.01, making the whole transaction’s value amount to 10,582,982. This particular insider is now the holder of 8,400 in total.
Rani Therapeutics Holdings Inc (RANI) Earnings and Revenue Records
Rani Therapeutics Holdings Inc’s EPS increase for this current 12-month fiscal period is 7.44% and is forecasted to reach -1.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -9.40% through the next 5 years, which can be compared against the 0.28% growth it accomplished over the previous five years trading on the market.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Let’s observe the current performance indicators for Rani Therapeutics Holdings Inc (RANI). It’s Quick Ratio in the last reported quarter now stands at 1.93. The Stock has managed to achieve an average true range (ATR) of 0.41.
In the same vein, RANI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.18, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.03 at the market close of one year from today.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
If we take a close look at the recent performances of Rani Therapeutics Holdings Inc (NASDAQ: RANI), its last 5-days Average volume was 17.3 million that shows progress from its year to date volume of 0.52 million. During the previous 9 days, stock’s Stochastic %D was recorded 24.86% While, its Average True Range was 0.49.
Raw Stochastic average of Rani Therapeutics Holdings Inc (RANI) in the period of the previous 100 days is set at 16.85%, which indicates a major fall in contrast to 35.26% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 282.29% that was higher than 131.54% volatility it exhibited in the past 100-days period.
